Munich-based DVC Deutsche Venture Capital has strengthened its life sciences team by appointing Dr Jan zur Hausen as partner. He was previously managing director of Mulligan BioCapital in Hamburg, where he has been since 2000.
MPM Asset Management LCC in Cambridge, MA employed Dr zur Hausen from 1996 to 1998, where he worked as a scientific analyst for the management consulting and M&A advisory firm MPM Capital Advisors. There he participated, among other projects, as a key member of the team advising one of the largest transactions between a pharmaceutical and biotechnology company, Bayer AG and Millennium Pharmaceuticals Inc.
Dr zur Hausen studied biology at the University of Hohenheim and was awarded a PhD in cell biology from the University of Basel.